Compare GSK Pharma with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ALEMBIC PHARMA - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA ALEMBIC PHARMA GSK PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 53.3 16.4 323.9% View Chart
P/BV x 12.0 6.5 183.8% View Chart
Dividend Yield % 1.3 0.6 225.8%  

Financials

 GSK PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ALEMBIC PHARMA
Mar-19
GSK PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3,595664 541.4%   
Low Rs1,253412 303.8%   
Sales per share (Unadj.) Rs184.7208.7 88.5%  
Earnings per share (Unadj.) Rs26.331.0 84.8%  
Cash flow per share (Unadj.) Rs29.237.1 78.6%  
Dividends per share (Unadj.) Rs20.005.50 363.6%  
Dividend yield (eoy) %0.81.0 80.7%  
Book value per share (Unadj.) Rs126.3144.2 87.6%  
Shares outstanding (eoy) m169.40188.52 89.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x13.12.6 509.1%   
Avg P/E ratio x92.217.4 531.0%  
P/CF ratio (eoy) x83.114.5 573.1%  
Price / Book Value ratio x19.23.7 514.2%  
Dividend payout %76.117.7 428.7%   
Avg Mkt Cap Rs m410,626101,461 404.7%   
No. of employees `0005.0NA-   
Total wages/salary Rs m5,3727,467 71.9%   
Avg. sales/employee Rs Th6,306.7NM-  
Avg. wages/employee Rs Th1,083.1NM-  
Avg. net profit/employee Rs Th898.0NM-  
INCOME DATA
Net Sales Rs m31,28139,347 79.5%  
Other income Rs m1,02394 1,090.8%   
Total revenues Rs m32,30439,441 81.9%   
Gross profit Rs m6,0098,736 68.8%  
Depreciation Rs m4861,152 42.2%   
Interest Rs m6184 3.3%   
Profit before tax Rs m6,5407,493 87.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,3731,568 151.4%   
Profit after tax Rs m4,4545,844 76.2%  
Gross profit margin %19.222.2 86.5%  
Effective tax rate %36.320.9 173.5%   
Net profit margin %14.214.9 95.9%  
BALANCE SHEET DATA
Current assets Rs m20,06119,577 102.5%   
Current liabilities Rs m14,54314,896 97.6%   
Net working cap to sales %17.611.9 148.3%  
Current ratio x1.41.3 105.0%  
Inventory Days Days5790 63.3%  
Debtors Days Days1445 31.0%  
Net fixed assets Rs m14,34327,097 52.9%   
Share capital Rs m1,694377 449.3%   
"Free" reserves Rs m19,70426,811 73.5%   
Net worth Rs m21,39827,188 78.7%   
Long term debt Rs m24,993 0.0%   
Total assets Rs m39,11347,778 81.9%  
Interest coverage x1,091.041.7 2,616.2%   
Debt to equity ratio x00.2 0.1%  
Sales to assets ratio x0.80.8 97.1%   
Return on assets %11.412.6 90.4%  
Return on equity %20.821.5 96.8%  
Return on capital %31.923.6 135.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53419,453 2.7%   
Fx outflow Rs m7,0916,065 116.9%   
Net fx Rs m-6,55713,388 -49.0%   
CASH FLOW
From Operations Rs m3,9948,120 49.2%  
From Investments Rs m-1,433-7,556 19.0%  
From Financial Activity Rs m-3,584590 -607.0%  
Net Cashflow Rs m-1,0231,153 -88.7%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 2.9 351.7%  
FIIs % 23.8 9.1 261.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 13.9 110.8%  
Shareholders   102,036 49,328 206.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   UNICHEM LAB  AUROBINDO PHARMA  STERLING BIOTECH  GLENMARK PHARMA  VENUS REMEDIES  

Compare GSK PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 848 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


May 17, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS